Clinical Trial Update: Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression [NA]

View source ↗

Summary

Completed clinical study assessing the Ketoflex 12/3 diet and its effect on progression in early-to-mid stage Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Prof. Lutfu Hanoglu, MD | Conditions: Alzheimer Type Dementia, Alzheimer's Disease (AD) | NA | Status: COMPLETED